CDKN2B and type 1 diabetes mellitus: T1DM patients also exhibited decreased mRNA levels of CDKN2A (variant 1 p16Ink4a), CDKN2A (p14Arf,variant 4), CDKN2B (p15Ink4b) and CDKN2BAS compared with controls.